Fig. 1
From: Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
HA-synthase transcript levels and the effect of SF on HAS3 expression in RCC cells. A, B: HA-synthase transcript (A) and HAS3 protein (B) expression in HK-2 and RCC cells (786-O, Caki-1, 769-P). C–F: RCC cells treated with SF for 48 h were analyzed for HAS3 transcript levels (C, D) or HAS3 protein expression (E, F) by RT-qPCR and immunoblotting, respectively. Panels A, C and D: HAS3 transcript levels were normalized to β-actin. The images are cropped for brevity. Uncropped images of the blots shown in panels B, E, and F are provided in the Additional file 1 (Appendix). Data: Mean ± SD (n = 3 or 4). Panel B, E, F: actin as the loading control